Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06432855

Genetic Determinants of the Antiviral Immune Response in Oceanian Populations

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Institut Pasteur · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Oceania's populations, including Melanesians, are paying a heavy price for dengue fever, which has been circulating actively in the region since the Second World War. In New Caledonia (NC), the incidence of dengue fever is higher among municipalities predominantly populated by Melanesians, suggesting that Melanesians may have an increased susceptibility to symptomatic dengue fever. Differences in antiviral immune responses between populations of different geographical origins are partly the result of population-specific immune regulatory variants. In turn, viruses have imposed considerable selective pressure on human populations. Although crucial to understanding their susceptibility to viral infections, the genetic determinants of the antiviral immune response of Oceanians remain to be characterized. In this context, the hypothesis is that the genetic origin of Oceanians, and Melanesians in particular, has shaped their antiviral immune response and contributes to their greater susceptibility to certain viral infections. The aim is to characterize the immune response to pathogens affecting the New Caledonian population, and in particular to dengue virus, of Melanesian and European populations, and to identify its genetic determinants. It will be explored whether saliva can be used as a non-invasive sample to study the seroprevalence of dengue in Oceanian populations.

Detailed description

Cross-sectional observational study with prospective sample and data collection Individuals will be identified from among eligible participants in the STEP-BSA21 and COVCAL studies. Information and consent Questionnaire, saliva collection on Oragene tube, buccal swabbing and 20 mL blood collection on CPT tube DNA extraction and low-coverage sequencing of participants' complete genomes And Isolation and in vitro stimulation of peripheral blood mononuclear cells (PBMCs) with dengue virus * single-cell RNA sequencing (scRNAseq) * multiplex quantification of cytokines and chemokines * bioinformatics analysis to identify genetic markers associated with a differential transcriptomic and secretory response to dengue virus stimulation.

Conditions

Interventions

TypeNameDescription
OTHERBlood collection20 ml-blood sample
OTHERsaliva collectionsaliva sample

Timeline

Start date
2024-06-15
Primary completion
2025-06-15
Completion
2027-12-15
First posted
2024-05-29
Last updated
2024-06-24

Locations

1 site across 1 country: New Caledonia

Source: ClinicalTrials.gov record NCT06432855. Inclusion in this directory is not an endorsement.